The Role of Congestion in Cardiorenal Syndrome Type 2: New Pathophysiological Insights into an Experimental Model of Heart Failure

Publisher： Karger

E-ISSN： 1664-5502|6|1|61-72

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.6, Iss.1, 2015-0, pp. : 61-72

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of the Cardiorenal Syndrome in Decompensated Heart Failure

By  

Cardiorenal Medicine, Vol. 4, Iss. 3-4, 2014-10 ,pp. : 176-188

Karger

Access to resources Recommend Favorite

Assessment and Management of Volume Overload and Congestion in Chronic Heart Failure: Can Measuring Blood Volume Provide New Insights

By  

Kidney Diseases, Vol. 2, Iss. 4, 2016-10 ,pp. : 164-169

Karger

Access to resources Recommend Favorite

Role of Vasopressin and Vasopressin Receptor Antagonists in Type I Cardiorenal Syndrome

By  

Blood Purification, Vol. 27, Iss. 1, 2009-01 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

The Interaction between Heart Failure, Renal Failure and Anemia – The Cardio-Renal Anemia Syndrome

By  

Blood Purification, Vol. 22, Iss. 3, 2004-07 ,pp. : 277-284

Karger

Access to resources Recommend Favorite

Pharmacologic Therapies for Chronic and Acute Decompensated Heart Failure: Specific Insights on Cardiorenal Syndromes

By  

Blood Purification, Vol. 37, Iss. 2, 2014-07 ,pp. : 20-33

Karger

Access to resources Recommend Favorite